Your treatment goals If you plan to lose more weight, you may need to continue tirzepatide for a longer time
Food Res Int 176:113801 Liao Y-C, Chang C-C, Nagarajan D, Chen C-Y, Chang J-S (2021) Algae-derived hydrocolloids in foods: applications and health-related issues
Stopping a GLP-1 medication abruptly can stall progress or lead to a return of hunger signals, making the availability of compounded alternatives essential for maintaining momentum in a weight loss journey
FDA-approved branded semaglutide (Wegovy, Ozempic) has been reviewed by the FDA for safety and effectiveness
Participants were divided into two groups: the first group had stopped GLP-1 treatment more than a year prior, and after 40 weeks on tirzepatide, they lost 4.8% of their body weight
GLP-1 Medications: A Weight-Inclusive Perspective on Pros and Cons Over the past few years, GLP-1 receptor agonists (like semaglutide and liraglutide) have captured public attention as game-changers in the treatment of type 2 diabetesand more recently, for weight loss